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Sudden unexplained death in epilepsy (SUDEP) is the
most common cause of premature mortality in epi-
lepsy and was linked to mutations in ion channels;
however, genes within the channel protein interac-
tome might also represent pathogenic candidates.
Here we show that mice with partial deficiency of
Sentrin/SUMO-specific protease 2 (SENP2) develop
spontaneous seizures and sudden death. SENP2 is
highly enriched in the hippocampus, often the focus
of epileptic seizures. SENP2 deficiency results in
hyper-SUMOylation of multiple potassium channels
known to regulate neuronal excitability. We demon-
strate that the depolarizing M-current conducted
by Kv7 channel is significantly diminished in
SENP2-deficient hippocampal CA3 neurons, pri-
marily responsible for neuronal hyperexcitability.
Following seizures, SENP2-deficient mice develop
atrioventricular conduction blocks and cardiac asys-
tole. Both seizures and cardiac conduction blocks
can be prevented by retigabine, a Kv7 channel
opener. Thus, we uncover a disease-causing role
for hyper-SUMOylation in the nervous system and
establish an animal model for SUDEP.
INTRODUCTION
Epilepsy is amajor medical condition with inherited and acquired
forms. Among those epileptic conditions linked to channelopa-
thies, mutations in potassium channel subunits represent the
largest category (Brenner andWilcox, 2012; Cooper, 2012; Noe-
bels, 2003). It has been estimated that the rate of sudden death is
20-fold higher in epilepsy patients than in the general population,
and sudden unexplained death in epilepsy (SUDEP) represents
the most common epilepsy-related cause of death (SillanpaaNeand Shinnar, 2010). The cause of SUDEP in human has not
been determined. In animal models, inactivation of potassium
channels genes has been linked to SUDEP (Goldman et al.,
2009; Glasscock et al., 2010). These animal models demon-
strated an important connection between the brain and the
heart. However, it remains unclear whether seizure and sudden
death are two separate manifestations of potassium channel
deficiency in the brain and the heart or seizure predisposes the
heart to lethal cardiac arrhythmia and death.
Inherited disorders of ion channels are a major source of hu-
man disease in excitable tissues. Mutation of individual subunits
of these heteromeric complexes gives rise to a wide variety of
neural and cardiac excitability disorders, yet genes involved in
their posttranslational modification within the membrane may
also be disease producing (Herren et al., 2013). For example,
Kv2.1, a voltage-gated potassium channel, contains 16 serine
phosphorylation sites in the cytoplasmic domain. Mutational
analysis revealed that phosphorylation at multiple series pro-
vided graded activity-dependent regulation of channel activity
(Park et al., 2006). Another posttranslational modification that
has been shown to affect Kv2.1 channel activity is SUMOylation
(Dai et al., 2009; Plant et al., 2011). Small ubiquitin-like modifier
(SUMO) covalently modifies a large number of cellular proteins;
SUMOylation is implicated in the regulation of multiple cellular
processes through its ability to alter protein localization, func-
tion, or protein-protein interaction (Yeh, 2009).
SUMOylation is catalyzed by SUMO-specific E1, E2, and E3s
and can be reversed by a family of Sentrin/SUMO-specific pro-
teases (SENPs) (Yeh et al., 2000). There are three different
SUMOs: SUMO-1, SUMO-2, and SUMO-3. SUMO-2 and
SUMO-3 are closely related and are usually called SUMO-2/3.
SUMO-1 modifies its substrate as a monomer, whereas
SUMO-2/3 forms polymeric chains. The SUMOylation status of
a particular substrate is dictated by the balance among SUMO
E1, E2, E3, and SENPs. There are six SENPs with different sub-
strate specificities (Yeh, 2009). Although the biochemical proper-
ties of SENPs have been well documented, their specific targets
and physiological roles are known only in a limited number of
cases. SENP1 or SENP2 knockout mouse embryos do noturon 83, 1159–1171, September 3, 2014 ª2014 Elsevier Inc. 1159
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that the SENPs are not redundant and have distinct substrate
specificity during development. SENP1 plays a key role in the
hypoxic response by regulating HIF1a stability (Cheng et al.,
2007), whereas SENP2 is involved in the binding of polycomb
complex to H3K27me3 (Kang et al., 2010) and in regulating
myostatin expression and myogenesis (Qi et al., 2014).
SUMOylation has also been shown to regulate ion channel ac-
tivity. For example, SUMOylation of K2P1 or Kv1.5 can inactivate
these potassium channels in Xenopus oocytes and myocytes,
and SUMOylation of Kv2.1 increases the excitability of hippo-
campal neurons (Benson et al., 2007; Plant et al., 2010; Plant
et al., 2011; Rajan et al., 2005). However, it is not known whether
ion channel regulation by SUMO in vitro may be implicated in
common disease phenotypes, and whether it is translatable to
animal models. In this report, we show that SENP2 deficiency
produces an animal model of seizures and sudden death closely
resembling SUDEP.We provide evidence that SENP2 deficiency
leads to hyper-SUMOylation of both Kv1.1 and Kv7.2/Kv7.3 in
hippocampal neurons. However, SUMOylation of Kv1.1 does
not significantly affect its channel activity. Remarkably, hyper-
SUMOylation of Kv7.2/Kv7.3 significantly diminishes the M-cur-
rent, which is primarily responsible for neuronal hyperexcitability.
The identification of the M-current as a main culprit in SENP2
deficiency is supported by the observations that both seizures
and AV blocks can be prevented by the Kv7 channel opener re-
tigabine. Our findings unravel an important physiological role of
SENP2 in regulation of the M-current and that reversing
SUMOylation may present a new approach for treating subsets
of individuals with SUDEP.
RESULTS
Seizures and Sudden Death in SENP2-Deficient Mice
Because SENP2 is required for expression of key developmental
genes, SENP2 deletion is embryonic lethal (Kang et al., 2010). To
explore the potential role of SENP2 in the regulation of biological
processes in adult mice, we generated mice homozygous for
a floxed SENP2 allele that contained a neomycin insert
(SENP2fxN/fxN), which displayed a postnatal phenotype (Figures
S1A and S1B available online). The SENP2fxN/fxN mice appeared
normal at birth; however, by the sixth postnatal week, thesemice
developed spontaneous convulsive seizures, followed by sud-
den death at 6–8 weeks postpartum with 100% penetrance (Fig-
ure 1A; Movie S1). To determine whether retention of the
neomycin cassette in the floxed allele may have contributed to
early lethality in SENP2fxN/fxN mice due to neighborhood effects
(Ren et al., 2002), we removed the cassette by FLP-mediated
recombination. The homozygous mice without neomycin
cassette (SENP2fx/fx) had a normal lifespan.
Inclusion of the neomycin cassette caused a reduction in
SENP2 transcripts (Figure 1B), and SENP2 protein level was
markedly reduced in SENP2fxN/fxN mice when compared with
SENP2+/+ or SENP2fxN/+ mice (Figures 1C and 1D), while the
SENP2 mRNA and protein levels were restored to normal in
SENP2fx/fx mice after removal of the neomycin cassette (Figures
S2A–S2C). The neomycin cassette insertion primarily affected
the SENP2 transcription because transcription of the Gm49431160 Neuron 83, 1159–1171, September 3, 2014 ª2014 Elsevier Inc.gene, which overlapped with SENP2 gene, was not affected by
insertion of neomycin cassette (Figure S2D). The reduction of
SENP2 protein led to accumulation of SUMO-1- or SUMO-2/3-
conjugated proteins in both the brain and cardiac tissues
(Figures S3A–S3C). This was not due to an increase in the
expression of either SUMO-1 or SUMO-2 message in the
SENP2fxN/fxN mice (Figures S3D and S3E). Thus, SENP2 defi-
ciency resulted in a hyper-SUMOylation state.
To determine the origin of the seizure phenotype, we moni-
tored freely moving adult mice implanted with chronic cortical
and hippocampal electroencephalogram (EEG) electrodes.
Video EEG recordings revealed low-amplitude desynchronized
cortical EEG activity and frequent bilateral interictal spike dis-
charges (10–120/hr) in SENP2fxN/fxN, but not in SENP2+/+, mice
(Figure 1E). Two types of spontaneous seizures, typically 10–
30 s in duration, were observed. The first type was bilaterally
generalized electrographic episodes with high voltage, rhythmic
spiking, and slower poly-spike/waves, terminating with minimal
postictal depression. During these purely electrographic sei-
zures, the mice continued to engage in exploratory behavior,
grooming, or remained motionless or asleep. Depth electrodes
revealed the presence of isolated hippocampal seizures that
failed to propagate to overlying neocortex (Figure 1F; Movie
S2), where only a decremental EEG pattern was evident without
interruption of behavior, lasting about 30 s. The second seizure
type consisted of wild running fits, involving convulsive tonic
and clonicmovements of all limbs and trunk, with absentminimal
cortical discharge, likely of brainstem origin without high-ampli-
tude cortical discharges, followed by postictal rigidity (Movie
S3), lasting about 15 s, and ultimately death.
Hyperexcitability in SENP2-Deficient Hippocampal
Neurons
Since SENP2 is highly expressed in the hippocampal formation
(Allen Brain Atlas; http://www.brain-map.org), we first examined
the excitability of these neuronal networks in brain slices.
SENP2+/+ orSENP2fxN/fxN brain slices did not demonstrate spon-
taneous field discharges in the CA3 pyramidal cell region when
bathed in normal saline solution. However, elevating the extra-
cellular K+ concentration from 2.5 mM to 7.5 mM induced a
significantly higher discharge rate in SENP2fxN/fxN slices as
compared to SENP2+/+, indicating an intrinsic network hyperex-
citability in SENP2fxN/fxN mice (Figures 2A and 2B).
We next examined firing properties of hippocampal CA3 pyra-
midal neurons with whole-cell patch-clamp recordings. The
spontaneous firing and the firing rate evoked by current injection
in CA3 neurons were much higher in SENP2fxN/fxN neurons than
in SENP2+/+ controls. Moreover, a repetitive burst behavior
was triggered by mossy fiber stimulation in CA3 neurons in
SENP2fxN/fxN mice but not in the control mice (Figures 2C–2F
and S4; Table S1). In light of both intrinsic and synaptically driven
neuronal hyperexcitability in SENP2fxN/fxN mice, we asked
whether addition of SENP2 could rescue the hyperexcitability
phenotype in a cell-autonomous way. When SENP2 peptide
was included in the pipette solution, we observed a marked
reduction in evoked firings of CA3 neurons in SENP2fxN/fxN
mice, while heat-denatured SENP2 (de-SENP2) did not change
excitability (Figures 2G and 2H). The SENP2 peptide markedly
Figure 1. SENP2 Deficiency Causes Sei-
zures and Sudden Death
(A) Lifespan of SENP2+/+ (n = 120), SENP2fxN/+ (n =
108), and SENP2fxN/fxN (n = 110) mice.
(B) Expression level of SENP2 transcripts in
brain and heart of SENP2+/+, SENP2fxN/+ and
SENP2fxN/fxN mice. SENP2 transcript level was
measured by real-time PCR, normalized to
SENP2+/+ control (n = 3 mice/group). The ANOVA
revealed a significant differences between the
groups from brain (F[2,6] = 48.94, p < 0.001) and
heart (F[2,6] = 137.1, p < 0.0001).
(C) Western blot analysis of brain and heart ex-
tracts of SENP2+/+, SENP2fxN/+, and SENP2fxN/fxN
mice with anit-SENP2 and anti-actin antibodies.
(D) The ratios of SENP2 protein to actin of
SENP2+/+, SENP2fxN/+, and SENP2fxN/fxN mice
were normalized to SENP2+/+ mice (n = 3 mice/
group). The ANOVA revealed a significant differ-
ences between the groups from brain (F[2,6] =
53.9, p < 0.001) and heart (F[2,6] = 296.8, p <
0.0001).
(E) Representative EEG seizures recorded from
awake SENP2fxN/fxNmice at 7 weeks of age (n = 3).
EEG traces revealed baseline low-amplitude de-
synchronized activity with frequent sharp interictal
spikes followed by onset of spontaneous non-
convulsive bilateral seizure.
(F) Representative traces recorded simultaneously
from the left cortex (upper) and the left hippo-
campus (lower) of SENP2fxN/fxN mice (n = 3). EEG
traces showed isolated electrographic hippo-
campal seizure; overlying cortex displays only a
decremental activity EEG pattern.
Values are shown as mean ± SEM. ***p < 0.001;
****p < 0.0001 by one-way ANOVA followed by
Dunnett’s test. See also Figures S1–S3 and
Movies S1, S2, and S3.
Neuron
SUMO, Seizures, and Sudden Deathreduced neuronal hyperexcitability around 2 min after adminis-
tration, while de-SENP2 had no effect (Figure 2I). Taken together,
these results indicate that aberrant burst firing and network
hyperexcitability in hippocampal neurons are attributable to
SENP2 deficiency.
Hyper-SUMOylation of Kv1.1 andKv7.2/Kv7.3 in SENP2-
Deficient Neurons
Interestingly, SENP2 is highly expressed in the hippocampus, a
critical brain region for genesis of seizures. Moreover, the brain
expression pattern of SENP2 precisely overlaps those of a num-
ber of voltage-gated potassium channels linked to the develop-
ment of temporal lobe epilepsy and early lethality (Allen Brain
Atlas). We hypothesized that SENP2 deficiency resulted in
hyper-SUMOylation of multiple potassium channels leading to
increased neuronal excitability in the hippocampal circuitry.Neuron 83, 1159–1171, SeSENP2 proteins are present at the nu-
clear envelope or in a subnuclear domain
in HeLa cells and endothelial cells (Kang
et al., 2010; Zhang et al., 2002a). How-
ever, the localization of SENP2 in hippo-
campal neurons has not yet beendetermined. We cultured hippocampal neurons from SENP2+/+
and SENP2fxN/fxN mice and analyzed the expression of Kv1.1
and Kv7.2, two voltage-gated potassium channels implicated
in epileptic seizures (Glasscock et al., 2010; Smart et al., 1998;
Singh et al., 1998, 2003). Immunofluorescence analyses showed
that SENP2, Kv1.1, and Kv7.2 colocalized in hippocampal neu-
rons (Figure 3A). The intensity of SENP2 was markedly reduced
in hippocampal neurons of SENP2fxN/fxNmice, while SENP2 defi-
ciency did not alter the apparent localization of Kv1.1 and Kv7.2
(Figure 3A) or Kv7.2 distribution between membrane and cyto-
solic areas (Figures S5A and S5B).
We next examined SUMOylation of Kv1.1 and Kv7 channels in
mouse brain tissue. Immunoprecipitation-western blot analysis
showed that SUMO-1- and SUMO-2-modified Kv1.1 bands
were highly enriched in the SENP2fxN/fxN brain (Figure 3B). Only
the SUMO-2-, but not the SUMO-1-, modified Kv7.2 bandptember 3, 2014 ª2014 Elsevier Inc. 1161
Figure 2. Hyperexcitability of Neuronal Network in SENP2-Deficient Neurons
(A) Representative traces of firing frequency in the CA3 neurons from the field recordings in SENP2+/+ and SENP2fxN/fxN brain slices superfused with artificial CSF
containing 7.5 mM potassium.
(B) Mean value of firing frequency in the CA3 neurons in the SENP2fxN/fxN brain slices (n = 33) was markedly increased compared with that in the SENP2+/+
slices (n = 34).
(legend continued on next page)
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Figure 3. Hyper-SUMOylation of Kv1.1 and Kv7.2 in SENP2fxN/fxN Neurons
(A) SENP2 colocalizes with Kv1.1 and Kv7.2 in hippocampal neurons. Neurons from the brains of SENP2+/+ and SENP2fxN/fxN mice were cultured for immu-
nocytochemistry with SENP2 (green) and Kv1.1- (red) or Kv7.2 (red)-specific antibodies. DAPI (blue) was used to show nuclei. Bars in all panels are 5 mm.
(B) Kv1.1 channels were modified by SUMO-1 and SUMO-2. The immunoprecipitates (IPs) with anti-Kv1.1 from brain lysates were detected by immunoblotting
(IB) with anti-SUMO-1, anti-SUMO-2, and anti-Kv1.1 antibodies.
(C) Kv7.2 channels were modified by SUMO-2, but not SUMO-1. IPs with anti-SUMO-1 or anti-SUMO-2/3 from brain lysates were detected by IB with anti-Kv7.2
antibody.
See also Figure S5.
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Kv7.1 and Kv7.3 were also modified by SUMO-2, and their
SUMOylations were enhanced in the SENP2fxN/fxN brain (Figures
S5C and S5D). Thus, SENP2 deficiency leads to hyper-
SUMOylation of both Kv1.1 and Kv7.2/Kv7.3 in hippocampal
neurons.(C) Representative traces of spontaneous firing (SF) and evoked firing of hippo
SENP2+/+ and SENP2fxN/fxN brain slices. The red arrows indicate the peaks elicite
SENP2fxN/fxN brain slices.
(D) Mean values of the SF and MFS-evoked firing frequencies in SENP2fxN/fxN neu
the SENP2+/+ neurons (n = 15 in SF and 10 in MFS).
(E) Representative traces of CA3 neuronal firing evoked by current injection (inpu
protocol shown in the insert).
(F) Mean values of the current injection evoked firing of CA3 neurons were signi
controls (n = 17). The ANOVA revealed a significant differences between the gro
(G) Representative traces of CA3 neuronal firing evoked by current injection (input
(de-SENP2, 250 pM) peptide in pipette solution (current injection protocol in the
(H) Inclusion of SENP2 (n = 10) but not heat-denatured SENP2 (n = 8) peptide in
mice. The ANOVA revealed a significant differences between the groups (F[1,77
(I) Time course of SENP2 or de-SENP2 on CA3 neuronal firing frequency. Applicat
firing frequency in CA3 neurons of SENP2fxN/fxNmice. Peptides were dissolved in t
100 pA). The mean values of spike number (Bin is 5 s) were normalized with the
Values are shown as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.00
test in (F) and (H). See also Figure S4 and Table S1.
NeHyper-SUMOylation of Kv7.2/Kv7.3 Diminishes
M-Currents and Contributes to Neuronal
Hyperexcitability
The SENP2fxN/fxN neurons had a less negative resting mem-
brane potential than wild-type controls (Figure S6A; Table S1).
This could be due to reduction of potassium currents fromcampal CA3 neurons by single mossy fiber stimulation (MFS) recorded from
d by MFS. The repetitive bursting behavior can only be evoked by MFS in the
rons (n = 12 in SF and 9 in MFS) were markedly increased when compared with
t = 0, 20, 40, and 60 pA) in SENP2+/+ and SENP2fxN/fxN mice (current injection
ficantly increased in SENP2fxN/fxN brain slices (n = 16) compared to SENP2+/+
ups (F[1,217] = 34.89, p < 0.0001).
= 0, 20, 40, and 60 pA) with SENP2 (250 pM) or heat-denatured, inactive SENP2
insert).
the pipette solution reduced hyperexcitability of CA3 neurons in SENP2fxN/fxN
] = 65.22, p < 0.0001).
ion of SENP2 (n = 9) but not de-SENP2 (n = 5) peptide significantly reduced the
he pipette solution, and the firingswere evoked by injecting currents (from 50 to
average of first min as 1.
01 by unpaired t test in (B) and (D) or two-way ANOVA followed by Bonferroni’s
uron 83, 1159–1171, September 3, 2014 ª2014 Elsevier Inc. 1163
Figure 4. Reduction in M-Current Contributes to Neuronal Hyperexcitability in SENP2fxN/fxN Mice
(A and B) Representative traces of deactivation tail currents in the absence (Ctl) or presence of Kv7 opener retigabine (RB) (10 mM) and blocker XE-991 (3 mM) in
the CA3 neurons of the SENP2+/+mice (A) and in their SENP2fxN/fxN littermates (B). The deactivation tail currents were elicited with the voltage protocol shown in
the insert.
(C) Mean values of the M-current densities show that the basal M-currents, which are defined as XE-991-sensitive tail currents, were significantly diminished in
the SENP2fxN/fxN neurons. Application of RB significantly potentiated the M-currents in neurons from both SENP2+/+ (n = 8) and SENP2fxN/fxN (n = 12) mice. The
ANOVA revealed a significant differences between the groups (F[3,36] = 19.65, p < 0.001).
(legend continued on next page)
Neuron
SUMO, Seizures, and Sudden Death
1164 Neuron 83, 1159–1171, September 3, 2014 ª2014 Elsevier Inc.
Neuron
SUMO, Seizures, and Sudden Deathhyper-SUMOylation of potassium channels. Indeed, we found
that the amplitude of whole-cell potassium currents of CA3 pyra-
midal neurons was significantly reduced in hippocampal neu-
rons from SENP2fxN/fxN mice compared to SENP2+/+ littermates
(Figures S6B and S6C). We asked whether reduction in the
whole-cell potassium current was due to reduced Kv1 and/or
Kv7 currents in the SENP2fxN/fxN mice. Unexpectedly, using the
Kv1.1-specific blocker dendrotoxin-K (DTX-K), we found that
the amplitude of Kv1.1 currents and firings of CA3 neurons did
not differ significantly between the SENP2fxN/fxN and SENP2+/+
mice (Figures S6D–S6H). In the hippocampus, Kv7.2 and Kv7.3
form a heteromeric channel, which conducts the hyperpolarizing
M-current to control membrane potential and neuronal activity
(Brown and Passmore, 2009; Hansen et al., 2008). Using a
standard deactivation voltage protocol (Passmore et al., 2003)
with 10,10-Bis(4-pyridinylmethyl)-9(10H)-anthracenone dihydro-
chloride (XE-991), a specific Kv7 blocker, we observed promi-
nent basal M-currents in the CA3 neurons in SENP2+/+ mice
(Figures 4A and 4C). In contrast, the basal M-currents in the
CA3 neurons in the SENP2fxN/fxN mice were significantly dimin-
ished (Figures 4B and 4C). Using retigabine, a specific Kv7
opener, we observed that the M-currents were potentiated in
the CA3 neurons in both SENP2+/+ and SENP2fxN/fxN mice
(Figures 4A–4C). These results were also consistent with our
data collected by using an activation voltage protocol (Figures
S6I–S6L).
To determine the role of Kv7 in the hyperexcitability of CA3
neurons in SENP2fxN/fxN mice, we examined the effects of XE-
991 on spontaneous and evoked firings by current injection.
When Kv7 channels were blocked by XE-991, the spontaneous
and evoked firings were markedly increased in SENP2+/+ neu-
rons (Figures 4D and 4E). CA3 neurons in SENP2fxN/fxNmice dis-
played a high firing rate at baseline, but their firings did not
further increase during XE-991 application (Figures 4D and 4F).
Likewise, potentiation of the M-currents by retigabine in the
SENP2fxN/fxN neurons led to substantial suppression of sponta-
neous and evoked firings by current injection (Figures 4G–4I).
Since SENP2 peptide reduced neuronal hyperexcitability in the
SENP2fxN/fxN neurons, we asked whether SENP2 could also
restore the diminished M-currents. As shown, there was a
marked increase in M-currents in CA3 neurons of SENP2fxN/fxN(D) Themean spontaneous firing frequency of CA3 neurons was significantly incre
no significant difference in SENP2fxN/fxN mice (n = 7/group).
(E and F) XE-991 application resulted in a significant increase in the current injectio
mice (F) (n = 16/group). The ANOVA revealed a significant differences between the
(F[1,84] = 0.09, p > 0.05).
(G) The mean spontaneous firing frequency of CA3 neurons was significantly decr
(H and I) RB application resulted in a significant decrease in the mean spontane
SENP2fxN/fxN (J) (n = 8/group) mice. The ANOVA revealed a significant differences
mice (F[1,98] = 63.57, p < 0.0001).
(J and K) Representative traces of deactivation tail currents in the absence (Ctl)
neurons of the SENP2fxN/fxN mice with SENP2 (250 pM) or heat-denatured inactiv
currents were elicited with the voltage protocol shown in the insert. To minimiz
presence of tetrodotoxin (0.5 mM) to block sodium currents, CdCl2 (100 mM) to bloc
block hyperpolarization-activated currents.
(L) Mean values of theM-current densities show that theM-currents, which are de
(n = 8) but not de-SENP2 (n = 6) in the SENP2fxN/fxN neurons.
Values are shown asmean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001
(C) or followed by Bonferroni’s test in (E), (F), (H), and (I). See also Figure S6 and
Nemice after infusion of SENP2 peptide, whereas de-SENP2 had
no effect (Figures 4J–4L). These results suggest that Kv7
channel function in the hippocampus is profoundly impaired in
SENP2fxN/fxN mice, and the impaired Kv7 channel function can
be restored by retigabine or SENP2 peptide. Taken together,
SENP2 deficiency in hippocampal neurons of SENP2fxN/fxN
mice diminishes the M-currents conducted by Kv7 channels,
contributing to the more positive resting membrane potential
and hyperexcitability of hippocampal neurons.
Recapitulation of the Sudden Death Phenotype with
Brain-Specific Deletion of SENP2
Since SENP2fxN/fxN mice develop epilepsy and die between 6
and 8 weeks of age, we hypothesized that SENP2fxN/fxN mice
may possess potentially lethal cardiac defects predisposing
them to early death. In order to identify the proximal cause of
death, we monitored the electrocardiogram (ECG) from freely
moving SENP2fxN/fxNmice and SENP2+/+ controls over a contin-
uous 1 week period. The ECG recordings showed that the
SENP2fxN/fxN mice displayed episodes of severe prolonged
bradycardia (Figures 5A, 5B, S7B, and S7D) and higher activity
(Figures S7A and S7C). In addition to sinus bradycardia, the
SENP2fxN/fxN mice also developed high-degree AV conduction
blocks and AV dissociation prior to lethal asystole (Figures 5A
and 5B). During the interictal periods between seizures,
SENP2fxN/fxN mice displayed longer AV block durations (Fig-
ure 5C) and higher frequency of blocks (Figure 5D) compared
to SENP2+/+ littermates.
Since SENP2 deficiency resulted in hyper-SUMOylation of
both brain and cardiac proteins (Figures S3A–S3C), it is unclear
whether sudden death is primarily neurogenic or cardiogenic.
Thus, we generated SENP2fx/fx mice and crossed with either
tamoxifen-inducible Thy1 or myosin heavy chain (MHC) pro-
moter-specific Cre mice. SENP2 mRNA was reduced to 15%
of baseline in the brain following five daily injections of tamoxifen
in the SENP2fx/fx-Thy1 mice (Figure 6A). On the other hand,
SENP2 mRNA dropped to 28% of baseline level in the heart in
SENP2fx/fx-MHC mice after identical tamoxifen treatment (Fig-
ure 6B). Depletion of SENP2 in cardiomyocytes had no apparent
effect on the development of behavioral seizures or lifespan of
the mice; however, depletion of SENP2 in the projection neuronased only in SENP2+/+mice (n = 8/group) following XE-991 application. There is
n evoked firing only in SENP2+/+mice (E) (n = 12/group) but not in SENP2fxN/fxN
groups inSENP2+/+ (F[1,112] = 54.78, p < 0.0001), but not inSENP2fxN/fxN, mice
eased by retigabine (RB) in both SENP2+/+ (n = 7) and SENP2fxN/fxN (n = 8) mice.
ous firing frequency of CA3 neurons from both SENP2+/+ (I) (n = 8/group) and
between the groups in SENP2+/+ (F[1,98] = 28.85, p < 0.0001) and SENP2fxN/fxN
or presence of Kv7 opener RB (10 mM) and blocker XE-991 (3 mM) in the CA3
e SENP2 (de-SENP2, 250 pM) peptide in pipette solution. The deactivation tail
e the contamination of other currents, all recordings were carried out in the
k calcium currents, DTX-K (100 nM) to block Kv1.1 currents, and Cs+ (1 mM) to
fined as XE-991-sensitive tail currents, were significantly potentiated by SENP2
by paired t test in (D), (G), and (L) or two-way ANOVA followed by Tukey’s test in
Table S1.
uron 83, 1159–1171, September 3, 2014 ª2014 Elsevier Inc. 1165
Figure 5. Severe Bradycardia and AV Con-
duction Blocks in SENP2fxN/fxN Mice
(A) Representative telemetric ECG traces recorded
from awake SENP2+/+ and SENP2fxN/fxN mice. The
ECG traces corresponded to time points as indi-
cated by arrows in Figures S7B and S7D: The
upper trace was recorded from a SENP2+/+
mouse; the bottom traces ([Aa]–[Ae]) were re-
corded at different time points from a representa-
tive SENP2fxN/fxN mouse; trace (Ae) indicates
death.
(B) Mean heart rates of SENP2+/+ (n = 3) and
SENP2fxN/fxN (n = 5) mice calculated from a 2-hr
periods at time intervals defined in Figures S7B
and S7D. The ANOVA revealed a significant dif-
ferences between the groups (F[5,22] = 65.91, p <
0.0001).
(C) Mean AV blocks were counted from ECGs re-
corded continuously for 7 days in SENP2+/+ (n = 3)
and SENP2fxN/fxN (n = 5) mice.
(D) Mean AV blocks were counted from the
ECGs recorded within the last 24 hr prior to the
death in SENP2+/+ (n = 3) and SENP2fxN/fxN (n = 5)
mice.
Values are shown asmean ± SEM. *p < 0.05; ***p <
0.001 by one-way ANOVA followed by Dunnett’s
test in (B) or unpaired t test in (C) and (D). See also
Figure S7.
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100%mortality within 11 days (Figure 6C). To determine cause of
death, we monitored freely moving adult mice implanted with
chronic cortical EEG electrodes. Video EEG recordings revealed
development of cortical seizures in the SENP2fx/fx-Thy1 mice
5 days after tamoxifen induction (Figure 6D). These mice also
developed severe bradycardia, high-degree AV block, and even-
tually asystole (Figures 6E–6H, S7F, and S7H) with lower activity
(Figures S7E and S7G). Thus, brain-specific, but not cardiomyo-
cyte-specific, deletion of SENP2 recapitulated the phenotype of
global SENP2 deficiency.
Prevention of Seizures and Cardiac Conduction Blocks
with Retigabine
We discovered that auditory stimulation (22.5 kHz for 10 s) can
reliably induce seizures in the SENP2fxN/fxN mice when they
reached 6 weeks of age (Movie S4). Seizures could be induced
1–5 s following activation of the acoustic signals and lasted for
10–20 s (indicated by noisy ECG baseline in bracket). This was
followed by a period of sinus pauses or AV conduction blocks
(Figure 7A). The sinus pauses and AV blocks were due to
seizure-induced increase in the parasympathetic tone because
atropine (1 mg/kg) was able to prevent postseizure sinus pauses
and AV blocks (Figure 7B). On the other hand, pretreatment with
propranolol (4mg/kg) caused more postseizure AV blocks (Fig-
ure 7B). As expected, neither atropine nor propranolol prevented
seizure induction (Figure 7B).
Since retigabine is able to open the Kv7 channels in the
SENP2fxN/fxN neurons, we asked whether retigabine can prevent
seizure induced by acoustic stimulation in theSENP2fxN/fxNmice.
To test this hypothesis, we first determined that seizures can be1166 Neuron 83, 1159–1171, September 3, 2014 ª2014 Elsevier Inc.induced in the 6-week-old SENP2fxN/fxNmice with acoustic stim-
ulation. These mice were rested for 6 hr and injected intraperito-
neally with either saline or retigabine (10 mg/kg) in a blinded
fashion. Thirty minutes following saline or retigabine injection,
mice were stimulated acoustically (22.5 kHz for 10 s). We found
that seizures can only be induced in saline-treated mice but not
in the retigabine-treated mice (Figure 7C). Since the retigabine-
treatedmice never developed seizure, there were no postseizure
AV blocks. This is consistent with the ability of retigabine to open
the Kv7 channel and to suppress hyperexcitability of the SENP2-
deficient neurons (Figures 4G–4I).
DISCUSSION
SUMO conjugation has been reported to modulate the function
of several neuronal K+ channels, including K2P1 (Rajan et al.,
2005), Kv1.5 (Benson et al., 2007), and Kv2.1 (Dai et al., 2009;
Plant et al., 2011). Kainate receptor-mediated excitatory post-
synaptic currents are decreased by SUMOylation and enhanced
by de-SUMOylation (Martin et al., 2007), suggesting that
SUMOylation is a general mechanism for regulating ion channel
physiology (Martin et al., 2007). However, these studies were all
based on in vitro findings, and the functional role of SUMOylation
on ion channel activity in living animals has not been previously
determined. The epileptic and sudden death phenotype of the
SENP2-deficient mice closely resembles that of Kv1.1-null
mice (Glasscock et al., 2010). Despite their coexpression in
CA3 neurons, hyper-SUMOylation of Kv1.1 channels due to
SENP2 deficiency did not cause a detectable reduction in
Kv1.1 current amplitude. On the other hand, the M-current,
which plays a critical role in controlling membrane potentials
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SUMO, Seizures, and Sudden Deathand firing activity (Brown and Passmore, 2009; Hansen et al.,
2008), was significantly diminished in the hippocampal neurons
of SENP2-deficient mice (Figures 4B and 4C). Although we
cannot exclude the involvement of other ion channels or recep-
tors, defective M-current can account for the neuronal hyperex-
citability observed in the SENP2-deficient mice.
There are five Kv7 channels, encoded by the KCNQ genes
(Brown and Passmore, 2009). Kv7.2 and Kv7.3 are the major
components of the M-current, which regulates neuronal excit-
ability (Scott and Holmes, 2012; Surti and Jan, 2005). Mutation
in the KCNQ1 gene at the LQT1 locus (11p15.5) is the most com-
mon cause of long QT syndrome (LQTS), which predisposes
patients to lethal cardiac arrhythmias (Goldenberg et al., 2008;
Wang et al., 1996). In the current study, SENP2-deficient mice
developed profound bradycardia and high-degree AV conduc-
tion blocks, but not ventricular arrhythmia (Figure 5A). The car-
diac conduction blocks usually followed by seizure activity and
can be prevented by atropine, but not propranolol (Figure 7B).
Thus, the high-degree AV blocks observed in SENP2-deficient
mice are likely due to an increase in parasympathetic tone
following seizures. Interestingly, the Kv7.1 channel encoded by
the KCNQ1 gene is also expressed in forebrain and brainstem
nuclei, and mice carrying human LQTS mutations in the
KCNQ1 gene also develop seizures and sudden death due to
an increase in parasympathetic tone (Goldman et al., 2009).
Furthermore, we found that mice with cardiomyocyte-specific
knockout of SENP2 had a normal lifespan (Figure 6C). In
contrast, brain-specific deletion of SENP2 resulted in 100%
mortality 11 days after tamoxifen induction. These mice also
developed severe seizures, high-degree AV blocks, and asys-
tole. Thus, the sudden death phenotype due to SENP2 defi-
ciency is most likely neurogenic. Taken together, defective Kv7
channel function can explain both seizures and sudden death
exhibited by the SENP2-deficient mice.
Retigabine is a third-generation antiepileptic drug that re-
ceived approval from the Food and Drug Administration (FDA)
for the treatment of partial-onset seizures. It is unique among
the antiepilepsy drugs approved by FDA because of its specific
mechanism of action. Retigabine activates Kv7.2-Kv7.5, but not
the Kv7.1, channel, through a hyperpolarization shift of the
voltage dependence of channel activation and an increase of
the channel maximal opening probability (Tatulian et al., 2001).
We showed that retigabine restored the M-currents (Figures 4B
and 4C), prevented spontaneous firings (Figure 4G), and abol-
ished current injection evoked firings (Figure 4I) in the hippo-
campal neurons of the SENP2-deficient mice. Furthermore,
retigabine can prevent stimulator-induced seizure and AV block
in the SENP2-deficient mice (Figure 7C). Notably, we did not
observe the repetitive bursting behavior in the CA3 neurons of
the SENP2-deficient mice in the presence of retigabine. The
burst firing behavior was triggered only by mossy fiber stimula-
tion, but not current injection at the soma of the CA3 neurons,
in the SENP2-deficient mice. The burst firing may originate
from increased dendritic excitability following synaptic stimula-
tion. Consistent with this interpretation, direct paired dendrite-
soma recordings have shown that current injection at the soma
elicits single action potentials, whereas current injection into
the apical trunk initiates burst firing in the dendrites of hippocam-Nepal neurons (Wong and Stewart, 1992). Taken together, these
results provide strong support that the molecular mechanism
accounting for seizures and sudden death in the SENP2-defi-
cient mice is due to hyper-SUMOylation of the Kv7 channels.
In summary, we have identified an animal model of SUDEP,
which is caused by alteration of a posttranslational protein modi-
fication pathway (SUMOylation) on a unique voltage-gated
potassium channel (Kv7.2/Kv7.3). This finding expands the num-
ber of biological pathways leading to critical ion channel disor-
ders in the central nervous system and validates SENP2 as a
candidate gene for SUDEP. Patients with epilepsy could be
screened for genetic variations of SENP2 that either reduces
its expression or activity. Retigabine or other Kv7 channel-spe-
cific openers should be explored for their utility in prevention of
seizures and sudden death in these individuals.
EXPERIMENTAL PROCEDURES
Generation of Mouse Strains and Animal Care
SENP2fxN/fxN mice were generated as shown in Figure S1. In brief, a genomic
clone containing exons 11–16 of the mouse SENP2 gene was isolated from a
BAC library and cloned into a vector using homologous recombination (Zhang
et al., 2002b). A cassette containing a loxP-flanked NeoR gene expressed from
the phosphoglycerate kinase promoter (PGK-NeoR) was cloned into intron
14 to obtain the final targeting vector. Following germline transmission,
SENP2fxN/+ mice were mated to obtain SENP2fxN/fxN knocking in mice and
wild-type littermates. After SENP2fxN/fxN crossing with FLP mice (Jackson
lab), the final allele without Neo cassette (SENP2fx/fx) was obtained. We estab-
lished mouse models with neuron-specific (SENP2fx/fx-Thy1) and cardiomyo-
cyte-specific (SENP2fx/fx-MHC) deletion of SENP2. SENP2fx/fx mice were
crossed with mice carrying Thy1 promoter (Thy1-cre/ERT2, -EYFP, Jackson
lab) or MHC promoter (a-MHC-MerCreMer, Jackson lab) and a fusion protein
containing Cre and mutated estrogen receptor.
Hippocampal Neuronal Culture
Hippocampal neuronal cultures were prepared from 1-day-old SENP2+/+ and
SENP2fxN/fxN pups. The hippocampal neurons were cultured in Neurobasal
supplemented with 2% B27 and 1% Glutamax-I (Invitrogen) in a humidified
atmosphere containing 5% CO2 at 37
C. Subsequent feeding occurred twice
weekly, each time replacing half the volume with medium including FGF2 and
AraC. The neurons were used for immunocytochemistry at DIV 14.
Immunocytochemistry
For immunolabeling, the fixed cells were permeabilized with 0.1%Triton X-100
in PBS, incubated with antibodies, and then examined by confocal laser scan-
ning microscopy (Leica).
RNA Isolation and Real-Time PCR
For mice genotyping, we isolated genomic DNA from tail clips using DiretPCR
lysis reagent (Viagen) and determined the genotypes of SENP2fxN/fxN,
SENP2fx/fx -Thy1, and SENP2fx/fx -MHC using PCR amplification of specific
alleles with indicated primers (Table S2). Quantitative PCRwas then performed
using reaction mixtures of 20 ng total RNA, 100 nM primers (Table S3), and
SYBR Green reagent (Applied Biosystems) with the ABI PRISM 7300 system
(Perkin-Elmer). PCRwas done in triplicate, and SDs representing experimental
errors were calculated. All data were analyzed using ABI PRISM SDS 2.0 soft-
ware (Perkin-Elmer).
Western Blotting and Immunoprecipitation
Whole mouse brain and heart were extracted, frozen in liquid nitrogen, and
subsequently homogenized on ice in lysis buffer with protease inhibitors.
Western blotting was done with primary anti-SENP2 (Santa Cruz), anti-
SUMO-1 (Cell Signaling), anti-SUMO-2 (Abacm), and anti-Kv7.2 (Alomone
labs) antibodies. For immunoprecipitation experiments, brain lysate wasuron 83, 1159–1171, September 3, 2014 ª2014 Elsevier Inc. 1167
Figure 6. Neuronal-Specific Deletion of SENP2 Causes Seizure and Sudden Death
(A) Expression level of SENP2 transcripts in brain and heart of SENP2+/+-Thy1 and SENP2fx/fx-Thy1 mice. SENP2 transcript levels were measured by real-time
PCR, normalized to SENP2+/+-Thy1 mice (n = 3 mice/group).
(legend continued on next page)
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Figure 7. Prevention of Acoustics-Induced
Seizures and AV Block in SENP2fxN/fxN Mice
with Retigabine
(A) Representative telemetric ECG traces recorded
from SENP2fxN/fxN mice following acoustics-
induced seizures. The onset of acoustic induction
(22.5 kHz for 10 s) is indicated by an arrow. The
noisy baseline indicated seizure activity (bracket).
The acoustic induction caused seizure followed by
AV blocks in saline administrated mice (n = 4).
(Aa and Ab) Magnified ECG traces showing AV
conduction blocks and sinus pauses.
(B) Representative telemetric ECG traces recorded
from SENP2fxN/fxN mice after acoustic stimulation
following 30 min pretreatment of atropine (1 mg/
kg, n = 6) or propranolol (4 mg/kg, n = 7). The
administration of atropine eliminated interictal AV
blocks, while pretreatment with propranolol wors-
ened AV blocks. Neither of them prevents the
acoustic-induced seizures. (Ba) Magnified normal
ECG traces; (Bb and Bc) Magnified traces showing
AV conduction blocks and sinus pauses.
(C) Representative telemetric ECG traces recorded
from SENP2fxN/fxN mice with pretreatment of re-
tigabine (10 mg/kg, n = 8) or saline (n = 5) followed
30 min later with acoustic stimulation (22.5 kHz for
10 s). The 30 min pretreatment of retigabine pre-
vented both acoustic-induced seizures and AV
blocks. (Ca and Cb) Magnified traces showing AV
conduction blocks and sinus pauses; (Cc) Magni-
fied normal ECG traces.
See also Movie S4.
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SUMO-1, and anti-SUMO-2 antibodies and followed by western immunoblot-
ting with anti-Kv7.2 and antibodies described above.(B) Expression level of SENP2 transcripts in brain and heart of SENP2+/+-MHC and SENP2fx/fx- MHC mice. S
PCR, normalized to SENP2+/+- MHC mice (n = 3mice /group).
(C) Lifespan of SENP2+/+ (n = 125), SENP2fx/fx-MHC (n = 130), and SENP2fx/fx-Thy1 (n = 120) mice.
(D) Representative EEG seizures recorded from awake SENP2fx/fx-Thy1 mouse after SENP2 neuronal-spe
amplitude desynchronized activity with frequent sharp interictal spikes followed by onset of spontaneous n
(E) Representative telemetric ECG traces recorded from awake SENP2+/+-Thy1 and SENP2fx/fx-Thy1 mice
indicated by arrows in Figures S7F and S7H. The upper trace was recorded from aSENP2+/+-Thy1mouse; the
times from a representative SENP2fx/fx-Thy1 mouse; trace (Ee) indicates death.
(F) Mean heart rates in SENP2+/+-Thy1 (n = 3) and SENP2fx/fx-Thy1 (n = 5) mice calculated from a 2-hr period
The ANOVA revealed a significant differences between the groups; F(5,22) = 130, p < 0.0001.
(G) Mean AV blocks per day were counted from ECGs recorded continuously for 5 days in SENP2+/+-Thy1
(H) Mean AV blocks were counted from the ECGs recorded within the last 24 hr before death in SENP2+/+-
SENP2fx/fx-Thy1 mice have longer AV block duration (F) and higher AV block frequency (G) when compared
Values are shown as mean ± SEM. *p < 0.05: ***p < 0.001; ****p < 0.0001 by unpaired t test in (A), (B), (G), and (
(F). See also Figure S7.
Neuron 83, 1159–1171, SeIn Vivo EEG/ECG or Telemetric ECG
Recordings
For EEG/ECG recordings, silver wire electrodes
soldered to a microminiature connector were
implanted bilaterally into the subdural space
over frontal and parietal cortex of mice under
avertin anesthesia several days prior to recording.
Behavioral video EEG/ECG monitoring and anal-
ysis were performed using a digital electroenceph-
alograph (Stellate Systems). For telemetric ECGrecording, a telemetry transmitter (ETA-F10, DSI) was implanted in the
abdominal cavity of each mouse with subcutaneous electrodes tunneled to
the right upper and left lower thorax (Kannankeril et al., 2006). ECG, heartENP2 transcript levels were measured by real-time
cific deletion. EEG traces revealed baseline low-
onconvulsive bilateral seizure.
. The ECG traces corresponded to time points as
bottom traces ([Ea]–[Ee]) were recorded at different
at indicated time intervals in Figures S7F and S7H.
(n = 3) and SENP2fx/fx-Thy1 (n = 5) mice.
Thy1 (n = 3) and SENP2fx/fx-Thy1 (n = 5) mice. The
to their SENP2+/+-Thy1 littermates.
H) or one-way ANOVA followed by Dunnett’s test in
ptember 3, 2014 ª2014 Elsevier Inc. 1169
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SUMO, Seizures, and Sudden Deathrate, and activity monitoring were performed using Dataquest software
(ART 4.0, DSI).
In Vitro Hippocampal Electrophysiological Recordings
Field recordings were made from the visually identified CA3 pyramidal cell
layer using a Getting Instruments Model 5A amplifier, digitized by a Digidata
1322A, and collected using Clampex. To calculate the burst frequency, we
let the slices equilibrate to 7.5 mM KCl for 5–15 min after beginning to burst
and then calculated the burst frequency over a 5 min interval using Clampfit
and Origin software.
For single-neuron current and firing recording, whole-cell configuration (in
current- or voltage-clamp mode) in hippocampal CA3 pyramidal neurons
was established under visual control using an upright microscope. The
total Kv currents were recorded in voltage-clamp mode in the presence of
TTX to block sodium channels and cadmium to block calcium channels.
To dissect Kv1.1 currents from the total Kv currents, the neurons were
perfused with a Kv1.1 channel blocker DTX-K after the total Kv currents
were recorded, such that the DTX-K-sensitive currents represent the Kv1.1
currents. To evaluate the Kv7/M-currents, the deactivation tail currents
(Passmore et al., 2003) were recorded sequentially in the presence of
retigabine and XE-991. To assess whether SENP2 can reverse the hyperex-
citability in the SENP2fxN/fxN neurons, SENP2 peptide (250 pM) in the pipette
solution was applied when recording the current injection evoked neuronal
firings. To evaluate the contributions of Kv1.1 or Kv7 channels to the hyper-
excitability manifesting in the SENP2fxN/fxN neurons, the same recordings in
the current-clamp mode were performed in the absence and presence of
DTX-K (100 nM), XE-991 (3 mM), or retigabine (10 mM) in bath solutions,
respectively.
Pharmacology and Acoustic Seizure Induction
SENP2fxN/fxN mice (6 weeks old) were administrated atropine (1 mg/kg;
Sigma) or propranolol (4 mg/kg; Sigma) for selective parasympathetic or
sympathetic blockade and retigabine (10 mg/kg; Alomone labs) for seizure
blockade. For each setting, resting telemetry ECG were continuously re-
corded before drug administration to establish the baseline rate of seizure
and AV blocks, injected with drug, and induced acoustic seizure via auditory
stimulation (Microson, 22.5 kHz) for 10 s half hour after injection, and then
recorded to determine the drug’s effect on the rate of seizure and AV
blocks. The seizures were induced with acoustic stimulation, and then the
SENP2fxN/fxN mice were rested for 6 hr and were injected with either saline
or each drug in a blinded fashion, and 30 min following injection, all mice
were stimulated with stimulator.
Statistical Analysis
All data were presented as mean ± SEM or SD of at least three separate ex-
periments. For electrophysiological experiments, both Clampex 9.0 software
(Molecular Devices) and MiniAnalysis 6.0 software (Synaptosoft Inc.) were
used to analyze firing and current waveform parameters. Statistical signifi-
cance was defined as p < 0.05 (*p < 0.05, **p < 0.01, ***p < 0.001, and
****p < 0.0001).
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